Intraprocedural Stent Thrombosis During Implantation of Sirolimus-Eluting Stents
- 8 June 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (22) , 2732-2736
Abstract
Background— Intraprocedural stent thrombosis (IPST) is a rare event ( Methods and Results— Between April 2002 and August 2003, 670 patients with 1362 lesions were treated with Cypher (Cordis, Johnson and Johnson Co) sirolimus-eluting stent implantation in San Raffaele Hospital and EMO Centro Cuore Columbus. Diabetes mellitus was present in 142 patients (21%), and 164 (24.5%) had unstable angina. Pretreatment with glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors was carried out in 235 patients (35%). Total stent length per vessel was 42.9±28.3 mm. IPST occurred in 5 patients (0.7%). None of the patients with IPST were pretreated with GP IIb/IIIa inhibitors. Using univariate exact logistic regression, only total stent length per vessel, in millimeters (exact OR, 1.03; 95% CI, 1.011 to 1.046; P =0.0028), was associated with the occurrence of IPST. Conclusions— Stent length was associated with the occurrence of IPST. Particular attention will need to be directed to this potential complication when long sirolimus-eluting stents are being used.Keywords
This publication has 15 references indexed in Scilit:
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Modified T‐stenting technique with crushing for bifurcation lesions: Immediate results and 30‐day outcomeCatheterization and Cardiovascular Interventions, 2003
- Preliminary Observations Regarding Angiographic Pattern of Restenosis After Rapamycin-Eluting Stent ImplantationCirculation, 2003
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet AggregationCirculation, 2003
- The Sirolimus-Eluting StentAmerican Journal of Cardiovascular Drugs, 2003
- Frequency and correlates of coronary stent thrombosis in the modern eraJACC, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2215–38.22Address for reprints: a single reprint of this document is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. This document (reprint no. 71-0205), as well as the companion full-text guideline (reprint no. 71-0206), are available on the ACC Web site at www.acc.organd the AHA Web site at http://www.americanheart.org. To purchase additional reprints (specify version): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org.JACC, 2001
- Subacute Stent Thrombosis in the Era of Intravascular Ultrasound-Guided Coronary Stenting Without Anticoagulation: Frequency, Predictors and Clinical OutcomeJACC, 1997
- Exact logistic regression: Theory and examplesStatistics in Medicine, 1995